文献速递多重用药老年综合评估

加拿大安大略省老年人孤独感与多重用药关联的性别差异

Sex-based differences in the association between loneliness and polypharmacy among older adults in Ontario, Canada.
PubMed 文献 · J Am Geriatr Soc · 2023-06-20

该研究基于加拿大社区健康调查-健康老龄化周期(2008/2009)与安大略省行政健康数据库链接的66岁及以上代表性子样本(n=2348,女性54.6%),采用性别分层多因素logistic回归分析孤独感与多重用药(≥5种同时处方药物)的关系。结果显示,严重孤独感在女性中与多重用药独立相关(OR=1.59;95%CI:1.01-2.50),在男性中该关联在多因素调整后减弱(OR=1.00;95%CI:0.56-1.80)。在多重用药者中,严重孤独的女性抗抑郁药处方比例(38.7% [95%CI:27.3-50.0])高于中度孤独女性(17.7% [95%CI:9.3-26.2])。

要点

  • 严重孤独感与老年女性多重用药独立相关(OR=1.59;95%CI:1.01-2.50),男性中未见此关联(OR=1.00;95%CI:0.56-1.80)。
  • 多重用药患病率在严重孤独的女性(44.1%)和男性(42.5%)中均为最高。
  • 多重用药者中,严重孤独女性抗抑郁药处方比例(38.7%)高于中度孤独女性(17.7%)。

核心结论

  • 严重孤独感与老年女性多重用药独立相关,而与老年男性多重用药无显著关联。
  • 临床医生应将孤独感视为药物审查和减药过程中重要的风险因素,尤其针对老年女性,以减少药物相关伤害。

研究设计与样本

  • 横截面分析,使用加拿大社区健康调查-健康老龄化周期(2008/2009)代表性数据,链接安大略省行政健康数据库,纳入66岁及以上受访者2348人(女性54.6%)。
  • 孤独感采用三条目孤独量表测量,分为不孤独、中度孤独、严重孤独;多重用药定义为同时处方5种及以上药物。
  • 采用性别分层多因素logistic回归模型(含调查权重)评估孤独感与多重用药的关系,并在多重用药者中分析处方药物亚类和潜在不适当药物的分布。

主要发现

  • 多重用药患病率在严重孤独女性中为44.1%(不孤独32.4%,中度孤独36.5%),在严重孤独男性中为42.5%(不孤独32.5%,中度孤独32.2%)。
  • 严重孤独与女性多重用药调整后OR=1.59(95%CI:1.01-2.50),男性调整后OR=1.00(95%CI:0.56-1.80)。
  • 多重用药者中,严重孤独女性抗抑郁药处方比例为38.7%(95%CI:27.3-50.0),中度孤独女性为17.7%(95%CI:9.3-26.2)。

临床怎么用

  • 临床医生应将孤独感视为药物审查和减药过程中重要的风险因素,尤其针对老年女性,以减少药物相关伤害。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging evidence shows loneliness is associated with polypharmacy and high-risk medications in older adults. Despite notable sex-based differences in the prevalence in each of loneliness and polypharmacy, the role of sex in the relationship between loneliness and polypharmacy is unclear. We explored the relationship between loneliness and polypharmacy in older female and male respondents and described sex-related variations in prescribed medication subclasses. METHODS: We performed a cross-sectional analysis of representative data from the Canadian Community Health Survey-Healthy Aging cycle (2008/2009) linked to health administrative databases in Ontario respondents aged 66 years and older. Loneliness was measured using the Three-Item Loneliness Scale, with respondents classified as not lonely, moderately lonely, or severely lonely. Polypharmacy was defined as five or more concurrently-prescribed medications. Sex-stratified multivariable logistic regression models with survey weights were used to assess the relationship between loneliness and polypharmacy. Among those with polypharmacy, we examined the distribution of prescribed medication subclasses and potentially inappropriate medications. RESULTS: Of the 2348 individuals included in this study, 54.6% were female respondents. The prevalence of polypharmacy was highest in those with severe loneliness both in female (no loneliness, 32.4%; moderate loneliness, 36.5%; severe loneliness, 44.1%) and male respondents (32.5%, 32.2%, and 42.5%). Severe loneliness was significantly associated with greater adjusted odds of polypharmacy in female respondents (OR = 1.59; 95% CI: 1.01-2.50) but this association was attenuated after adjustment in male respondents (OR = 1.00; 95% CI: 0.56-1.80). Among those with polypharmacy, antidepressants were more commonly prescribed in female respondents with severe loneliness (38.7% [95% CI: 27.3-50.0]) compared to those who were moderately lonely (17.7% [95% CI: 9.3-26.2]). CONCLUSIONS: Severe loneliness was independently associated with polypharmacy in older female but not male respondents. Clinicians should consider loneliness as an important risk factor in medication reviews and deprescribing efforts to minimize medication-related harms, particularly in older women.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Im JHB, Bronskill SE, Strauss R, et al. Sex-based differences in the association between loneliness and polypharmacy among older adults in Ontario, Canada. J Am Geriatr Soc. 2023. PMID: 37338145. doi:10.1111/jgs.18477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。